Найти книгу: "Manufacturing of Pharmaceutical Proteins"

Structured like a textbook, the second edition of this reference covers all aspects of biopharmaceutical manufacturing, including legal and regulatory issues, production facility design, and quality assurance, with a focus on supply chain management and regulations in emerging markets and cost control. The author has longstanding industrial expertise in biopharmaceutical production and years of experience teaching at universities. As such, this practical book is ideal for use in academia as well as for internal training within companies.

Content

Introduction

Planning and design

Rob tool kit

Welding

"Dog Bowl"

The rear of the fuel tank

The bed seat

Installing the wing

Air filter cover

Exhaust pipes

Production of the wing

Spoiler

A business-based rallying cry to reclaim the US economy There is a nagging feeling that the U.S. is slipping as a nation and our people are powerless to do anything to fix it. Issues such as jobs, product quality and safety, wages, the economy, and our status as the world's leading superpower are all tied together with our massive trade deficit. Re-Made in the USA addresses these issues using the author's firsthand observations and analysis, and offers a practical plan for how we can get our economy and global status back. A practical action plan to get the nation back on track If you're worried about America when you start reading this book, you'll finish feeling empowered Todd Lipscomb has a distinguished record in international business America's future does not have to be on the decline. In inspiring terms, Re-Made in the USA lays out the choice Americans have between doing nothing, and doing what we do best-rolling up our sleeves and working hard to fix the problem.

An in-depth look at big pharma's flagship company The Merck Druggernaut takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business. Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain's New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain's, she spearheads the publication of two to three special healthcare issues per year.

The book addresses the basics, applications, and manufacturing of plasmid biopharmaceuticals. The survey of the most relevant characteristics of plasmids provides the basics for designing plasmid products (applications) and processes (manufacturing). Key features that the authors include in the book are: i) consistency and clear line of direction, ii) an extensive use of cross-referencing between the individual chapters, iii) a rational integration of chapters, iv) appellative figures, tables and schemes, and v) an updated, but selected choice of references, with a focus on key papers.